MUC5AC and lung carcinoma: Additionally, MUC5AC interacts with PRRC1 to enhance tumor glycosylation, which in turn boosts angiogenesis and metastatic potential (184).Overexpression of MUC5AC has been associated with cisplatin resistance in lung cancer cells.